Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Molecular Vision
|
July 26, 2013
Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants
Kaoru Fujinami, Kazushige Tsunoda, Natsuko Nakamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 28, 2025
MHC II-restricted presentation of soluble antigen by naïve B cells is impaired upon engagement with membrane-associated antigen: A potential mechanism to mitigate autoreactivity
Thiago M Steiner, Yu Kato, Peck Szee Tan, et al.
Cancer Chemotherapy and Pharmacology
|
September 5, 2019
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma
Yuto Yamada, Yuta Ohno, Yu Kato, et al.
Cells
|
February 12, 2025
Comprehensive Search for Genes Involved in Thalidomide Teratogenicity Using Early Differentiation Models of Human Induced Pluripotent Stem Cells: Potential Applications in Reproductive and Developmental Toxicity Testing
Yu Kato, Takeshi Inaba, Koudai Shinke, et al.
Blood Purification
|
January 30, 2020
In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters
Toshihisa Hiraiwa, Kazuhiro Moriyama, Kana Matsumoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 2, 2019
Classical Type 1 Dendritic Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection
Christopher M Harpur, Yu Kato, Shinta T Dewi, et al.
Journal of Neurogastroenterology and Motility
|
May 20, 2016
Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease
Toshihiko Tomita, Yu Kato, Mayu Takimoto, et al.
Plos One
|
February 28, 2019
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
Yu Kato, Kimiyo Tabata, Takayuki Kimura, et al.
The Journal of Infectious Diseases
|
July 27, 2022
Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 Infection
Yu Kato, Nathaniel I Bloom, Peifang Sun, et al.
Cells
|
February 26, 2026
Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development
Yu Kato, Naoki Yamamoto, Yuichiro Uchida, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Molecular Vision
|
July 26, 2013
Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants
Kaoru Fujinami, Kazushige Tsunoda, Natsuko Nakamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 28, 2025
MHC II-restricted presentation of soluble antigen by naïve B cells is impaired upon engagement with membrane-associated antigen: A potential mechanism to mitigate autoreactivity
Thiago M Steiner, Yu Kato, Peck Szee Tan, et al.
Cancer Chemotherapy and Pharmacology
|
September 5, 2019
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma
Yuto Yamada, Yuta Ohno, Yu Kato, et al.
Cells
|
February 12, 2025
Comprehensive Search for Genes Involved in Thalidomide Teratogenicity Using Early Differentiation Models of Human Induced Pluripotent Stem Cells: Potential Applications in Reproductive and Developmental Toxicity Testing
Yu Kato, Takeshi Inaba, Koudai Shinke, et al.
Blood Purification
|
January 30, 2020
In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters
Toshihisa Hiraiwa, Kazuhiro Moriyama, Kana Matsumoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 2, 2019
Classical Type 1 Dendritic Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection
Christopher M Harpur, Yu Kato, Shinta T Dewi, et al.
Journal of Neurogastroenterology and Motility
|
May 20, 2016
Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease
Toshihiko Tomita, Yu Kato, Mayu Takimoto, et al.
Plos One
|
February 28, 2019
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
Yu Kato, Kimiyo Tabata, Takayuki Kimura, et al.
The Journal of Infectious Diseases
|
July 27, 2022
Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 Infection
Yu Kato, Nathaniel I Bloom, Peifang Sun, et al.
Cells
|
February 26, 2026
Rapid Drug Sensitivity Profiling via a Novel High-Success-Rate Culture Method for Patient-Derived Pancreatic Cancer: An Exploratory Preclinical Platform for Advancing Clinical Applications and Drug Development
Yu Kato, Naoki Yamamoto, Yuichiro Uchida, et al.
Page
of 10